Does OSIMERTINIB Cause Paronychia? 180 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 180 reports of Paronychia have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.7% of all adverse event reports for OSIMERTINIB.
180
Reports of Paronychia with OSIMERTINIB
0.7%
of all OSIMERTINIB reports
22
Deaths
47
Hospitalizations
How Dangerous Is Paronychia From OSIMERTINIB?
Of the 180 reports, 22 (12.2%) resulted in death, 47 (26.1%) required hospitalization, and 10 (5.6%) were considered life-threatening.
Is Paronychia Listed in the Official Label?
Yes, Paronychia is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Paronychia?
PANITUMUMAB (443)
AFATINIB (344)
FLUOROURACIL (292)
OXALIPLATIN (263)
CETUXIMAB (186)
CAPECITABINE (165)
ERLOTINIB (159)
TRASTUZUMAB (147)
DOCETAXEL (142)
IRINOTECAN (141)
Which OSIMERTINIB Alternatives Have Lower Paronychia Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN